Genelux's Series B Round

Genelux raised a round of funding on May 14, 2003.

Genelux is a clinical stage biopharmaceutical company with a mission to change the way in which cancer is diagnosed and treated. The company has developed an oncolytic virus-based technology platform …

Articles about Genelux's Series B Round: